SCTX 8-K: SEC filing
Scribe Therapeutics
Filed with the SEC on · accession 0001193125-26-458486
SCTX filed a 8-K (current report) with the SEC on Nov 12, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved +0.8% by the first close after the filing.
Summary of the filing
Scribe Therapeutics announced its financial results for the quarter ended September 30, 2026 and provided a business update via an earnings press release furnished as Exhibit 99.1.
Key details
How SCTX stock reacted
Close before
$16.86
Nov 11, 2026
First close after
+0.77%
$16.99
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for SCTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SCTX?
Click hereFrequently asked questions
What did SCTX file with the SEC on Nov 12, 2026?
SCTX filed a 8-K (SEC filing). Scribe Therapeutics announced its financial results for the quarter ended September 30, 2026 and provided a business update via an earnings press release furnished as Exhibit 99.1.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did SCTX stock react to this filing?
SCTX closed at $16.86 before the filing and $16.99 on Nov 12, 2026 (+0.77%).
Other SCTX SEC filings
Get alerts when SCTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days